A new study has found that over 30 percent people are afraid of taking pills daily to prevent cardiovascular disease (CVD) that they rather opt for a shorter life.
The study conducted by American Heart Association analyzed people with an average age of 50 and established that more than 8 percent of people were willing to trade almost 2 years of their life to avoid taking daily medication for cardiovascular disease, whereas 21 percent would trade between one week and a year of their lives.
In addition to people who were ready to keep their lives at stake, there were around 21 percent of people who said they would pay 1,000 dollar or more to avoid taking a pill each day for the rest of their lives.
There were around 70 percent of participants who were not interested to trade any weeks of their lives to avoid taking a CVD pill daily, and 62 percent weren't willing to gamble any risk of immediate death.
Robert Hutchins, M.D., M.P.H., lead author said that the act of having pills on daily basis can have a large effect on an individual's quality of life, and even a small reductions in quality of life like those found in this study, can have very large effects on the cost-effectiveness of that drug for a population.
The study is published in Cardiovascular Quality and Outcomes journal of American Heart Association.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
